毛喉萜对大鼠成骨样细胞内Ca^2＋释出的影响

毛喉萜是一种二萜类化合物,为细胞中腺苷酸环化酶的激活剂,用毛喉萜处理大发习成骨样细胞,发现它可即时激发细胞内Ｃａ＾２＋水平的增高,当细胞经毛喉萜长期处理（１－２天）后,其对ＰＴＨ激发细胞内Ｃａ＾２＋释出的交应也呈增高反应,但毛喉萜的即刻反应与其长期效应的作用机理可能并不相同,鉴于毛喉萜具有抑制增殖的作用,其对细胞内Ｃａ＾２＋ 水平的调节作用或与其对细胞的抑增殖促分化有关。     

毛喉萜对人胃癌细胞BGC－823中蛋白激酶C及其亚类的影响

以人胃癌细胞ＢＧＣ－８２３为模型,研究了毛喉萜（ｆｏｒｓｋｏｌｉｎ）对胃癌细胞中蛋白激酶Ｃ活性及其亚类基因表达的作用,同时也观察了毛喉萜对癌基因ｃ－ｊｕｎ及抑癌基因ｐ５３表达的影响．结果表明,２×１０~（－５）ｍｏｌ／Ｌ毛喉萜处理ＢＧＣ－８２３细胞７２ｈ,细胞质、膜和细胞核ＰＫＣ活性下降,ＰＫＣ亚类β,γ基因表达被抑制,癌基因ｃ－ｊｕｎ的表达也明显降低,而抑癌基因ｐ５３表达升高,上述变化可能是毛喉萜抑制胃癌细胞增殖等生理效应的重要分子事件。     

双歧杆菌粘附体外肠上皮细胞的钙信号传递的研究

本文采用钙荧光探剂 Ｆｌｕｏ—３／ＡＭ染色法,定量研究了双歧杆菌１０２７株、肠致病性大肠杆菌（ＥＰＥＣ）对体外肠上皮细胞Ｌｏｖｏ细胞株粘附的钙信号传递机制。结果表明,双歧杆菌１０２７株粘附可引起Ｌｏｖｏ细胞内Ｃａ~＋２随时间延长而梯度升高,但双歧杆菌１０２７株的作用远不如ＥＰＥＣ明显。同时发现双歧杆菌粘附引起Ｌｏｖｏ。细胞内Ｃａ~２＋升高主要源于细胞外Ｃａ~２＋内流所致,这与ＥＰＥＣ粘附引起宿主细胞内Ｃａ~２＋升高主要源于细胞内Ｃａ~２＋储池的Ｃａ~２＋释放不同。ＥＰＥＣ粘附引起宿主细胞内Ｃａ~２＋大幅度升高是其致病的重要信号传递基础;而双歧杆菌粘附仅引起宿主细胞内Ｃａ~２＋轻度升高,可能是其作为生理性细菌与肠上皮细胞和谐共生的信号传递基础。     

毛喉萜抑制人胃癌细胞BGC－823增殖与ras基因表达相关性研究

毛喉萜（ｆｏｒｓｋｏｌｉｎ）对人胄癌细胞ＢＧＣ－８２３增殖有明显抑制作用,具药物剂量和作用时间之依赖性。剂量为２×１０~（－５）ｍｏｌ／Ｌ之毛喉萜使胃癌细胞在软琼脂中形成集落的能力显著降低;癌基因ｃ－Ｈａ－ｒａｓ之表达明显被抑制,细胞核中与ｒａｓ基因上游调控区２．５ｋｂ片段结合的三种蛋白结合能力下降。联系到以同样浓度药物处理胃癌细胞７２ｈ,细胞质、膜与细胞核中蛋白激酶Ｃ（ＰＫＣ）活性均下降的现象,可能ＰＫＣ活性下降与Ｈａ－ｒａｓ基因上游片段２．５ｋｂ结合蛋白之结合能力下降存在相关性,ＰＫＣ可能通过影响ＤＮＡ结合蛋白的磷酸化作用,导致了Ｈａ－ｒａｓ基因表达之被阻抑。而ｒａｓ基因表达下降可能是毛喉萜抑制胃癌细胞增殖的一个重要分子事件。     

凝血酶对荧光标记的人单个血小板游离[Ca^2＋]和膜电位的动态影响

本文将ｆｌｕｏ－３和ｄ_ｉ－ＢＡ－Ｃ４（３）荧光标记的血小板固定于纤维蛋白原表面,以５７０型粘附式细胞仪（ＡＣＡＳ５７０）动态观察了凝血酶激活的人单个血小板细胞内游离［Ｃａ~（２＋）］（钙离子浓度）和膜电位的变化。静息状态时细胞游离［Ｃａ~（２＋）］和膜电位荧光较低,波动不明显。当加入０．１Ｕ／ｍｌ凝血酶激活时,［Ｃａ~（２＋）］（细胞内游离钙离子浓度）与膜电位迅速升高,随后［Ｃａ~（２＋）］出现反复振荡,幅度达约５００荧光单位,而膜电位基本上保持峰值水平。［Ｃａ~（２＋）］_ｉ升高与膜电位变化在时间和程度上不一致。本文结果提示,凝血酶引起血小板［Ｃａ~（２＋）］振荡和膜去极化,后者不是Ｃａ~（２＋）内流引起的。     

G蛋白在亮啡肽诱导心肌细胞内钙释放中的作用

本实验采用分离的ＳＤ大鼠心室肌细胞,以Ｆｕｒａ－２ＡＭ荧光指示剂负载,检测心肌细胞内游离钙浓度（Ｃａ＾２＋）变化。探讨亮啡肽（ＬＥＫ）对（Ｃａ＾２＋）的作用及其机制。实验结果：ＬＥＫ（６０μｍｏｌ／Ｌ）能升高（Ｃａ＾２＋）移去细胞外液钙此效应仍能出现,用ｃａｆｆｅｉｎｅ （５ｍｍｏｌ／Ｌ）耗竭细胞内钙池的钙,该效应消失,纳洛酮（１００μｍｏｌ／Ｌ）,百日咳毒素（２００ｎｇ／Ｌ）处理８－１０ｈ及ｐｒ     

降钙素基因相关肽对缺氧时海马细胞内游离Ca^2＋的影响

本实验用Ｆｕｒａ－２荧光测定技术直接监测了缺氧时大鼠海马细胞内游离Ｃａ２＋浓度（［Ｃａ２＋］ｉ）的变化,并观察了降钙素基因相关肽（ＣＧＲＰ）对这种变化的影响。结果发现,缺氧可使海马细胞［Ｃａ２＋］ｉ显著增高;４或８ｎｍｏｌ／ＬＣＧＲＰ能明显地降低缺氧引起的［Ｃａ２＋］ｉ增高,但在无胞外Ｃａ２＋的情况下,ＣＧＲＰ的作用消失。结果表明,ＣＧＲＰ的降钙作用是通过抑制缺氧时胞外Ｃａ２＋的内流来实现的。     

钙调素拮抗剂对人肺癌细胞增殖抑制及与cAMP信号系统相关性之初探

对钙调素（ＣａＭ）拮抗剂—三氟拉嗪（ｔｒｉｆｌｕｏｐｅｒａｚｉｎｅ,ＴＦＰ）在人肺癌细胞ＰＬＡ８０１的增殖抑制中的作用和ＣａＭ与ｃＡＭＰ信号系统水平的变化进行了研究．用５、１０、１５和２０μｍｏｌ／ＬＴＦＰ处理人肺癌细胞时观察到ＴＦＰ在抑制细胞内ＣａＭ活性的同时,抑制了细胞的增殖．药物处理的细胞在软琼脂中形成的集落数减少且明显小于对照组细胞．使用流式细胞光度术分析细胞周期的结果表明：１０μｍｏｌ／ＬＴＦＰ处理抑制了Ｇ１期细胞向Ｓ期的转移．当用１０μｍｏｌ／ＬＴＦＰ作用细胞５ｍｉｎ时,细胞内ｃＡＭＰ水平达到正常水平的１．８倍,直到３ｈ仍明显高于正常水平．同时,ｃＡＭＰ依赖的ＰＫＡ的活性在加药后１５ｍｉｎ上升到正常水平的２．８倍,直到加药３ｈ．活性仍保持较高水平,结果表明：钙调素功能的抑制,提高了ＰＬＡ－８０１细胞内ｃＡＭＰ系统的水平,Ｃａ２＋－ＣａＭ和ｃＡＭＰ－ＰＫＡ两个信号系统的协调作用,抑制了细胞的增殖     

低频、低压交变电场对成骨细胞增殖的影响

低频、低压交变电场能够促进成骨细胞的增殖。成骨细胞受交变电场作用以后,运用ＭＴＴ方法和流式细胞术,检测细胞的增殖情况。结果表明：电场作用后的细胞,与对照组细胞相比,细胞数目增多,Ｓ期细胞百分比增高。运用荧光标记技术检测细胞膜流动性以及胞内游离Ｃａ２＋浓度（［Ｃａ２＋］ｉ）的变化,初步探索电场对细胞增殖影响的作用机制。     

神经节苷脂（Gangliosides）对人红细胞膜Ca~（2＋）－Mg~（2＋）ATPase的影响

神经节苷脂（Ｇａｎｇｌｉｏｓｉｄｅｓ）是红细胞膜Ｃａ~（２＋）－Ｍｇ~（２＋）ＡＴＰａｓｅ的一种激活剂,这种激活作用也是依赖于Ｃａ~（２＋）存在。在２００μｍｏｌ／ＬＣａ~（２＋）存在的反应体系中,１００μｇ／ｍＬＧａｎｇｌｉｏｓｉｄｅｓ对Ｃａ~（２＋）－Ｍｇ~（２＋）ＡＴＰａｓｅ的激活作用最大,为基本酶活性的１５０％以上。实验还发现ＣａＭ拮抗剂三氟拉嗪（ＴＦＰ）、粉防已碱（Ｔｅｔ）等也同样抑制Ｇａｎｇｌｉｏｓｉｄｅｓ的这种激活作用。其抑制的ＩＣ_（５０）值为２５μｍｏｌ／Ｌ和３０μｍｏ１／Ｌ;而此浓度下抑制剂存在的反应体系中,对Ｃａ~（２＋）－Ｍｇ~（２＋）ＡＴＰａｓｅ的基本活性影响不大。     

Regulation of cytosolic calcium by cAMP and cGMP in freshly isolated smooth muscle cells from bovine trachea

The regulation of the cytosolic calcium concentration was investigated in freshly isolated adult bovine tracheal smooth muscle cells using fura 2. These cells contain 1.1 and 1.8 pmol of cGMP kinase and cAMP kinase per mg protein, respectively. Carbachol, histamine, serotonin, isoproterenol, and salbutamol increased the cytosolic calcium in a dose-dependent manner from 79 nM to about 650 nM. Preincubation of these cells for 20 min with isoproterenol, forskolin, 8-Br-cAMP and 8-(4-Cl-phenyl)thio-cAMP did not lower carbachol-induced increases in cytosolic calcium concentration, whereas the phorbol ester 12-O-tetradecanoylphorbol 13-acetate, the atrionatriuretic factor, isobutylmethylxanthine, and 8-Br-cGMP lowered cytosolic calcium. The active fragment of cGMP kinase, but not the catalytic subunit of cAMP kinase lowered carbachol-induced calcium levels. Carbachol released calcium from intracellular stores and increased calcium influx from the extracellular space. The influx was inhibited by preincubation with the calcium channel blockers nitrendipine or gallopamil. Both carbachol-stimulated pathways were suppressed by 8-Br-cGMP. Isoproterenol increased only the influx of calcium from the outside by a channel which was blocked by calcium channel blockers or 8-Br-cGMP. Forskolin and 8-Br-cAMP lowered carbachol- and isoproterenol-stimulated increases in calcium when added shortly before or after the addition of the agonist. In addition, isoproterenol decreased carbachol-stimulated calcium levels when added 10 s after carbachol. The calcium stimulatory effect of isoproterenol was abolished by preincubation of the cells with pertussis toxin or cholera toxin. These results show (a) that the beta 2-adrenoceptor couples in isolated tracheal smooth muscle cells to a dihydropyridine- and pertussis toxin-sensitive calcium channel; (b) that the same channel is opened by carbachol; (c) that cGMP kinase is very effective in decreasing elevated cytosolic calcium concentrations, whereas cAMP-dependent protein kinase has a variable effect on stimulated cytosolic calcium levels.     

The role of calcium in follicle-stimulating hormone signal transduction in Sertoli cells.

Sertoli cells are hormonally regulated by follicle-stimulating hormone (FSH) acting upon a G-protein-linked cell surface FSH receptor. FSH increases intracellular cyclic AMP but the involvement of other signal transduction mechanisms including intracellular calcium in FSH action are not proven. Using freshly isolated rat Sertoli cells we measured cytosolic free ionized calcium levels by dual-wavelength fluorescence spectrophotometry using the calcium-sensitive fluorescent dye Fura2-AM. The cytosolic calcium concentration in unstimulated Sertoli cells was 89 +/- 2 nM (n = 151 experiments) and was markedly increased by either calcium channel ionophores (ionomycin, Bay K8644) or plasma membrane depolarization consistent with the presence of voltage-sensitive and -independent calcium channel in Sertoli cell membranes. Ovine FSH stimulated a specific, sensitive (ED50, 5.0 ng of S-16/ml), and dose-dependent (maximal at 20 ng/ml) rise in cytosolic calcium commencing within 60 s to reach levels of 192 +/- 31 nM after 180 s and lasting for at least 10 min. The effect of FSH was replicated by forskolin, cholera toxin, and dibutyryl cyclic AMP, suggesting that cyclic AMP may mediate the FSH-induced rise in cytosolic calcium. The FSH-induced rise in cytosolic calcium required extracellular calcium and was abolished by calcium channel blockers specific for dihydropyridine (verapamil, nicardipine), nonvoltage-gated (ruthenium red) or all calcium channels (cobalt). Thus FSH action on Sertoli cells involves a specific, rapid, and sustained increase in cytosolic calcium which requires extracellular calcium and involves both dihydropyridine-sensitive, voltage-gated calcium channels and voltage-independent, receptor-gated calcium channels in the plasma membranes of rat Sertoli cells. The replication by cyclic AMP of the effects of FSH suggests that calcium may be a signal-amplification or -modulating mechanism rather than an alternate primary signal transduction system for FSH in Sertoli cells.     

Trypanosoma cruzi: calcium ion movement during internalization in host HeLa cells

The role of cytosolic Ca2+ and cytoplasmic calcium movement during the parasitization of HeLa cells by T. cruzi were studied. The level of calcium in parasitized cells increased compared to the control cells. Our experiments demonstrate that this cytosolic calcium originates from the release of the intracellular calcium deposits, especially from the mitochondria of the host cell. The parasitization rates decreased after the cells were treated with drugs to increase the cytosolic Ca2+ levels to inhibit the host-cell calmodulin.     

Inhibition by adenosine 3':5'-monophosphate of eicosanoid and platelet-activating factor biosynthesis in the mouse PT-18 mast cell.

A mouse spleen-derived mast cell line (PT-18) was employed to examine the mechanisms of adenosine 3':5'-monophosphate (cAMP)-mediated inhibition of antigen-induced lipid mediator biosynthesis. Specifically, we tested the hypothesis that increasing cAMP in mast cells inhibits lipid mediator biosynthesis by a mechanism independent of effects on histamine release (degranulation) or changes in cytosolic calcium concentration. Forskolin inhibited antigen-induced prostaglandin D2 (PGD2), leukotriene C4 (LTC4), and leukotriene B4 (LTB4) production by 30-50%. In contrast, forskolin had no inhibitory effect on antigen-induced increases in cytosolic calcium concentration, as monitored by the calcium indicator fura-2, or histamine release from the cells. The combination of the phosphodiesterase inhibitor isobutylmethylxanthine with forskolin inhibited the antigen-induced production of PGD2 and LTC4 by 90-100% and histamine release by about 60%. These responses were accompanied by a virtual abolition of the antigen-induced increase in cytosolic calcium. To test further the hypothesis that increasing cAMP can lead to inhibition of lipid mediator biosynthesis in the absence of effects on cytosolic calcium, we employed the calcium ionophores A23187 and ionomycin. Forskolin alone or in combination with isobutylmethylxanthine had no effect on ionophore-induced increases in cytosolic calcium but effectively inhibited leukotriene biosynthesis. In addition, increasing cyclic AMP led to an inhibition of ionophore-induced production of platelet-activating factor and liberation of arachidonic acid. These data suggest that a relatively modest increase in cAMP-dependent protein kinase activity in mast cells leads to inhibition of the lipase-catalyzed cleavage of arachidonic acid from membrane phospholipids in the absence of measurable effects on either histamine release or changes in cytosolic calcium concentration. This effect results in a selective inhibition of the biosynthesis of lipid mediators including LTC4, LTB4, PGD2, and platelet-activating factor.     

Alpha 1- and beta-adrenergic regulation of intracellular Ca2+ levels in brown adipocytes

In order to monitor changes in cytosolic Ca2+ levels, brown-fat cells were incubated with the fluorescent Ca2+-indicator fura-2 and the fluorescence intensity ratio followed. The addition of norepinephrine led to a rapid and persistent increase in the cytosolic Ca2+ level, which was dose-dependent with a maximal effect at about 1 microM. The response was diminished in the absence of extracellular Ca2+ and was inhibited more efficiently by phentolamine and prazosin than by propranolol or yohimbine, indicating alpha 1-adrenergic mediation. Accordingly, selective alpha 1-adrenergic stimulation also increased the cytosolic Ca2+ level. However, selective beta-adrenergic stimulation, as well as the adenylate cyclase activator forskolin, were also able to increase the cytosolic Ca2+ level in these cells to a certain extent. It was concluded that the major part of the increase in cytosolic Ca2+ was mediated, as in other cell types, via alpha 1-adrenergic receptors, but that Ca2+ levels were also positively modulated by a cAMP-mediated process. These observations are discussed in relation to known alpha 1/beta synergisms in brown adipose tissue.     

Sphingosine 1-phosphate promotes antigen processing and presentation to CD4+ T cells in Mycobacterium tuberculosis-infected monocytes

It was previously shown that cells die with increased cytosolic ATP after stimulation with apoptotic inducers including staurosporine (STS). To identify the source of apoptotic ATP elevation, we monitored, in real time, the cytosolic ATP level in luciferase-expressing HeLa cells. A mitochondrial uncoupler or a respiration chain inhibitor was found to decrease cytosolic ATP by about 50%. However, even when mitochondrial ATP synthesis was suppressed, STS induced a profound elevation of intracellular ATP. In contrast, the STS-induced ATP increase was prevented by any of three inhibitors of the glycolytic pathway: 2-deoxyglucose, iodoacetamide, and NaF. The STS effect strongly depended on intracellular calcium and was mimicked by a calcium ionophore. We conclude that Ca(2+)-dependent activation of anaerobic glycolysis, but not aerobic mitochondrial oxidative phosphorylation, is responsible for the STS-induced elevation of ATP in apoptotic HeLa cells.     

Ouabain-induced enhancement of rat mast cells response. Modulation by protein phosphorylation and intracellular pH

The digitalic glicoside ouabain induces potentiation of rat mast cell histamine release in response to several stimuli, which is mediated by Na+/Ca2+ exchanger. In this work, we studied the effect of ouabain on cytosolic calcium, intracellular pH and histamine release with Ca2+ ionophore A23187 in conditions designed to maximize ouabain-induced potentiation of rat mast cells response. The effect of protein kinase C (PKC), cAMP and phosphatase inhibition was also tested. Ouabain induced an enhancement in histamine release, cytosolic calcium and intracellular pH. The adenylate cyclase activator forskolin reduced the effect of ouabain on histamine release and intracellular pH, but enhanced the effect on cytosolic calcium. PKC activator PMA enhanced the effect of ouabain on histamine release and cytosolic calcium, without affecting intracellular pH. A PKC inhibitor, GF-109203X, reduced ouabain-induced enhancement of histamine release and intracellular pH, but increased the enhancement on cytosolic calcium. Finally, inhibition of protein phosphatases 1 and 2A with okadaic acid, increased the effect of ouabain on histamine release and intracellular pH, but reduced cytosolic calcium in presence of ouabain. This result suggest that ouabain-induced potentiation of rat mast cell histamine release with A23187 is modulated by kinases, and this modulation may be carried out by changes in intracellular alkalinization. However, the mechanism underlying cellular alkalinization remains to be elucidated.     

Modulatory effect of cyclic AMP on calcium fluxes in FRTL-5 cells

The aim of the present study was to investigate the effect of cAMP on calcium fluxes in Fura 2 loaded thyroid FRTL-5 cells. Preincubating the cells with the phosphodiesterase inhibitor Ro-201724 decreased the ATP-stimulated entry of calcium, while having no effect on the release of sequestered calcium. Pretreatment with forskolin decreased both the release of sequestered calcium and the entry of calcium in response to ATP. We then incubated the cells with phenylisopropyl adenosine (PIA), a P₂₁-receptor agonist earlier shown to decrease cAMP in FRTL-5 cells. Although we did not observe a decrease in cellular cAMP after PIA, the ATP-evoked calcium response was enhanced. Forskolin decreased calcium entry induced by thapsigargin a Ca^2?-ATPase inhibitor, but forskolin had no effect on the thapsigargin-evoked release of sequestered calcium. Addition of calcium to cells stimulated with ATP in a calcium-free buffered resulted in a rapid influx of calcium. This response in [Ca²⁺]_i was decreased in cells pretreated with forskolin. In cells stimulated with thapsigargin, the increase in [Ca²⁺]_i after addition of calcium was inhibited in part by forskolin and enhanced by PIA. The results suggest that cAMP may regulate calcium fluxes in FRTL-5 cells Furthermore, PIA increased agonist-induced calcium entry through a presently unknown mechanism. © 1993 Wiley-Liss, Inc.     

Nerve growth factor treatment or cAMP elevation reduces Ca2+/calmodulin-dependent protein kinase III activity in PC12 cells

Ca2+/calmodulin-dependent protein kinase III (Ca2+/CaM kinase III) phosphorylates a protein of Mr = 100,000 (the 100-kDa protein), a major substrate for Ca2+/CaM-dependent protein phosphorylation found in many mammalian tissues and cell lines (Nairn, A.C., Baghat, B., and Palfrey, H.C. (1985) Proc. Natl. Acad. Sci. U.S.A. 82, 7939-7943). Treatment of PC12 cells with nerve growth factor (NGF) or forskolin resulted in a decrease in the depolarization-dependent phosphorylation of the 100-kDa protein in intact cells and in a decrease in the Ca2+/CaM-dependent phosphorylation of the 100-kDa protein in cytosolic extracts. In experiments using cytosolic extracts, the initial effect of NGF on the phosphorylation of the 100-kDa protein was observed in less than 1 h, was maximal (70% decrease) after 12 h, and began to recover after 24 h. The effect of forskolin was more rapid and the maximal effect was greater (90-95% decrease). Decreased Ca2+/CaM kinase III activity was also found in PC12 cells treated with epidermal growth factor, 2-chloroadenosine plus isobutylmethylxanthine, or dibutyryl cAMP. The effect of forskolin did not reverse unless it was removed. Cycloheximide blocked the recovery of Ca2+/CaM kinase III activity observed following the removal of forskolin but did not affect the ability of forskolin to reduce kinase activity. Short-term treatment with phorbol ester had little effect on Ca2+/CaM kinase III activity; long-term treatment with phorbol ester, which results in the disappearance of enzymatically detectable protein kinase C, had no effect on the ability of NGF or 2-chloroadenosine to reduce Ca2+/CaM kinase III activity. The level of the 100-kDa protein as determined by immunological techniques was not changed by any treatment. These results suggested that the effect of treatment of PC12 cells with NGF or forskolin was to reduce the level of Ca2+/CaM kinase III per se.     

Forskolin Stimulates Adenylate Cyclase Activity, Cyclic AMP Accumulation, and Adrenocorticotropin Secretion from Mouse Anterior Pituitary Tumor Cells

Abstract: The effects of forskolin, an adenylate cyclase activator, were investigated on adrenocorticotropin (ACTH) secretion from AtT-20/D16-16 mouse pituitary tumor cells. Forskolin increased adenylate cyclase activity in these cells in the absence of added guanyl nu-cleotide, an effect blocked by somatostatin. Cyclic AMP synthesis and ACTH secretion increased in a concentration-dependent manner, not only in the clonal cells, but in primary cultures of rat anterior pituitary as well. Somatostatin inhibited cyclic AMP synthesis and ACTH secretion in response to forskolin. When forskolin was coapplied with corticotropin releasing factor, cyclic AMP synthesis was potentiated and ACTH secretion additive. The calcium channel blocker, nifedipine, inhibited forskolin, and 8-bromocyclic AMP stimulated ACTH secretion. These data suggest that ACTH secretion may be regulated at the molecular level by changes in cyclic AMP formation, which in turn regulate a calcium gating mechanism.